Protalix BioTherapeutics
PLX
#8915
Rank
S$0.18 B
Marketcap
S$2.24
Share price
-1.14%
Change (1 day)
-0.89%
Change (1 year)

Protalix BioTherapeutics (PLX) - Net assets

Net assets on the balance sheet as of June 2025 : S$64.66 Million

According to Protalix BioTherapeutics 's latest financial reports the company has S$64.66 Million in net assets.
A companyโ€™s net assets is the sum of its assets minus the sum of its liabilities.

Protalix BioTherapeutics - Net assets on balance sheet (from 2001 to 2025)

Net assets by year

Year Net assets Change
2024-12-31$S$58.73 M32.48%
2023-12-31$S$44.33 M-410.81%
2022-12-31$-S$14.27 Million74.8%
2021-12-31$-S$8.17 Million-77.19%
2020-12-31$-S$35.77 Million-62.27%
2019-12-31$-S$94.81 Million31.23%
2018-12-31$-S$72.25 Million83.36%
2017-12-31$-S$39.4 Million173.4%
2016-12-31$-S$14.42 Million-193.7%
2015-12-31$S$15.38 M-120.93%
2014-12-31$-S$73.47 Million115.2%
2013-12-31$-S$34.15 Million731.61%
2012-12-31$-S$4.11 Million-87.84%
2011-12-31$-S$33.78 Million131.54%
2010-12-31$-S$14.59 Million-165.41%
2009-12-31$S$22.29 M-64.84%
2008-12-31$S$63.42 M-30.8%
2007-12-31$S$91.64 M146.11%
2006-12-31$S$37.23 M266.93%
2005-12-31$S$10.14 M1156.67%
2004-12-31$S$0.8 M-27.48%
2003-12-31$S$1.11 M-19.39%
2002-12-31$S$1.38 M-21.11%
2001-12-31$S$1.75 M

Net assets for similar companies or competitors

Company Net assets differencediff. Country
Amicus Therapeutics
FOLD
S$0.29 B 361.74%๐Ÿ‡บ๐Ÿ‡ธ USA
Neurocrine Biosciences
NBIX
S$3.89 B 5,918.88%๐Ÿ‡บ๐Ÿ‡ธ USA
Pfizer
PFE
S$120.64 B 186,453.91%๐Ÿ‡บ๐Ÿ‡ธ USA
Teva Pharmaceutical Industries
TEVA
S$9.40 B 14,436.20%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel